S

Selux Diagnostics, Inc

83 employees

SeLux Diagnostics is a developer of the next-generation phenotyping platform that enables personalized antibiotic therapies for patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Therapeutics

Date founded

2014

Funding rounds raised

Total raised

$50M

from 14 investors over 14 rounds

S

Selux Diagnostics, Inc raised $8M on July 12, 2022

Investors: Biomedical Advanced Research and Development Authority (BARDA)

S

Selux Diagnostics, Inc raised $30M on June 1, 2022

Investors: Oxford Finance LLC

S

Selux Diagnostics, Inc raised $50M on February 28, 2022

Investors: Sands Capital Management, Northpond Ventures, Schooner Capital and RA Capital Management, L.P.

S

Selux Diagnostics, Inc raised $2.8M on October 19, 2021

Investors: National Institutes of Health

S

Selux Diagnostics, Inc raised $15M on June 8, 2021

Investors: Biomedical Advanced Research and Development Authority (BARDA)

S

Selux Diagnostics, Inc raised $9.6M on April 27, 2020

Investors: Biomedical Advanced Research and Development Authority (BARDA)

S

Selux Diagnostics, Inc raised $9M on August 29, 2019

Investors: Northpond Ventures

S

Selux Diagnostics, Inc raised $25M on December 12, 2018

Investors: RA Capital Management, L.P., Northpond Ventures and Schooner Capital

S

Selux Diagnostics, Inc raised $24M on April 10, 2018

Investors: Northpond Ventures

FAQ